Paper36967758
Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology.
Zhao J and 3 others. Front Endocrinol (Lausanne), 2023. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology. Papers, record 36967758. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36967758
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Non-alcoholic Fatty Liver Disease | Major topic |
| Osteoporosis | Major topic |
| Bone Diseases, Metabolic | Major topic |
| Humans | |
| Bone and Bones |
Source PubMed
References93
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34858025 | Efficacy and Safety of Teprotumumab in Thyroid Eye Disease. | Ther Clin Risk Manag | 2021 | https://conductscience.org/library/papers/34858025 | PubMed |
| 2 | 25552151 | Serum fetuin-A levels in postmenopausal women with osteoporosis. | Turk J Med Sci | 2014 | https://conductscience.org/library/papers/25552151 | PubMed |
| 3 | 23277412 | The role of fetuin-A in physiological and pathological mineralization. | Calcif Tissue Int | 2013 | https://conductscience.org/library/papers/23277412 | PubMed |
| 4 | 19096390 | Regulation of T-helper-cell lineage development by osteopontin: the inside story. | Nat Rev Immunol | 2009 | https://conductscience.org/library/papers/19096390 | PubMed |
| 5 | 23151457 | Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet. | Osteoarthritis Cartilage | 2013 | https://conductscience.org/library/papers/23151457 | PubMed |
| 6 | 35121343 | LCAT- targeted therapies: Progress, failures and future. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/35121343 | PubMed |
| 7 | 30600540 | Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density. | Aliment Pharmacol Ther | 2019 | https://conductscience.org/library/papers/30600540 | PubMed |
| 8 | 9537849 | Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment. | J Hepatol | 1998 | https://conductscience.org/library/papers/9537849 | PubMed |
| 9 | 32722080 | Early-Life Supplementation of Bovine Milk Osteopontin Supports Neurodevelopment and Influences Exploratory Behavior. | Nutrients | 2020 | https://conductscience.org/library/papers/32722080 | PubMed |
| 10 | 16567827 | Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. | Diabetes Care | 2006 | https://conductscience.org/library/papers/16567827 | PubMed |
| 11 | 24161214 | IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand. | J Transl Med | 2013 | https://conductscience.org/library/papers/24161214 | PubMed |
| 12 | 20451522 | Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. | Gastroenterology | 2010 | https://conductscience.org/library/papers/20451522 | PubMed |
| 13 | 23146032 | Role of fetuin-A in atherosclerosis associated with diabetic patients. | J Pharm Pharmacol | 2012 | https://conductscience.org/library/papers/23146032 | PubMed |
| 14 | 20440096 | Msx2 mediates the inhibitory action of TNF-alpha on osteoblast differentiation. | Exp Mol Med | 2010 | https://conductscience.org/library/papers/20440096 | PubMed |
| 15 | 19589948 | The role of liver-derived insulin-like growth factor-I. | Endocr Rev | 2009 | https://conductscience.org/library/papers/19589948 | PubMed |
| 16 | 26959184 | A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects. | Cell Metab | 2016 | https://conductscience.org/library/papers/26959184 | PubMed |
| 17 | 31980251 | Targeting FGF21 for the Treatment of Nonalcoholic Steatohepatitis. | Trends Pharmacol Sci | 2020 | https://conductscience.org/library/papers/31980251 | PubMed |
| 18 | 33868162 | Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/33868162 | PubMed |
| 19 | 29946735 | Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement. | JAMA | 2018 | https://conductscience.org/library/papers/29946735 | PubMed |
| 20 | 18348696 | Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation. | J Bone Miner Res | 2008 | https://conductscience.org/library/papers/18348696 | PubMed |
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42857025 | MAFLD and impaired bone formation in children: association with reduced serum LCAT. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42857025 | PubMed |
| 42827877 | Reprogramming bone homeostasis: The recoupling-oriented framework of bidirectional regulation strategies for osteoporosis. | iScience | 2026 | https://conductscience.org/library/papers/42827877 | PubMed |
| 42755564 | In utero and lactational exposure to tenofovir disoproxil fumarate and bone health outcomes: a scoping review of 31 studies. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42755564 | PubMed |
| 42663876 | Inulin alleviates metabolic dysfunction-associated steatotic liver disease-induced bone loss potentially by activating the Nrf2/GPX4 signaling pathway. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/42663876 | PubMed |
| 42524416 | Mechanistic insights and evidence-based management of metabolic dysfunction-associated steatotic liver disease (MASLD; formerly NAFLD) through combined diet and exercise interventions: an evidence-based narrative review. | J Clin Biochem Nutr | 2026 | https://conductscience.org/library/papers/42524416 | PubMed |
| 42176029 | Identification of the critical immune-related drivers shared by non-alcoholic fatty liver disease and osteoporosis. | Cell Mol Life Sci | 2026 | https://conductscience.org/library/papers/42176029 | PubMed |
| 41938109 | Alcohol consumption exacerbates high-fat diet-mediated disruptions in myelopoiesis and osteoclastogenesis in mouse models of metabolic dysfunction-associated liver diseases. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41938109 | PubMed |
| 41834911 | Long-term Western diet feeding impairs hepatic vitamin D metabolism and promotes bone loss in mice. | EXCLI J | 2026 | https://conductscience.org/library/papers/41834911 | PubMed |
| 41817922 | Trabecular bone score enhances fracture risk stratification in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus. | J Endocrinol Invest | 2026 | https://conductscience.org/library/papers/41817922 | PubMed |
| 41732262 | FXR in bone metabolism: An emerging regulator. | iScience | 2026 | https://conductscience.org/library/papers/41732262 | PubMed |
| 41717545 | Anoctamin 5 mutation leads to abnormal bone homeostasis of GDD by regulating AMPK-dependent glucose metabolism. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41717545 | PubMed |
| 41689231 | Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample. | BMJ Open | 2026 | https://conductscience.org/library/papers/41689231 | PubMed |
| 41546042 | LncRNA TUG1 promotes osteogenic differentiation of human umbilical cord mesenchymal stem cells by regulating miR-138/SIRT1 axis. | J Orthop Surg Res | 2026 | https://conductscience.org/library/papers/41546042 | PubMed |
| 41502978 | Dynamic modelling of liver-bone axis: A microphysiological approach to hepatic osteodystrophy. | Bioact Mater | 2026 | https://conductscience.org/library/papers/41502978 | PubMed |
| 41458554 | Osteosarcopenia in metabolic dysfunction-associated steatotic liver disease: from mechanisms to management. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41458554 | PubMed |
| 41388723 | Osteopontin: a central hub in the pathogenesis and therapeutic intervention of liver disease. | Ann Med | 2025 | https://conductscience.org/library/papers/41388723 | PubMed |
| 40901580 | Hepatic osteodystrophy: An underrecognized metabolic bone disease. | World J Hepatol | 2025 | https://conductscience.org/library/papers/40901580 | PubMed |
| 40894198 | Kangshujiangu granules improve NAFLD via cross-organ autophagy activation shared with osteoporosis. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40894198 | PubMed |
| 40607347 | Effects of dietary glycerol, vitamin C and niacinamide supplementation on liver of growing-finishing pigs. | Front Vet Sci | 2025 | https://conductscience.org/library/papers/40607347 | PubMed |
| 40594911 | Sexual dimorphism of MASLD-driven bone loss. | Sci Rep | 2025 | https://conductscience.org/library/papers/40594911 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36967758
GET https://conductscience.org/api/papers/v1/36967758/references?page=2